Business
Daiichi Sankyo : Participation in WHO-GBCI Phase 2 through a Partnership with City Cancer Challenge (C/Can) — Contributing to Breast Cancer Care in Low- and Middle-Income Countries
Daiichi Sankyo : Participation in WHO-GBCI Phase 2 through a Partnership with City Cancer Challenge (C/Can) — Contributing to Breast Cancer Care in Low- and
About this update from Daiichi Sankyo Company, Limited
[{"type":"text","content":"Daiichi Sankyo has identified contributing to cancer care for low- and middle-income countries (LMICs) as one of its key priorities in its global health initiatives focused on access to healthcare. Based on this policy, the company will participate in Phase 2 of the WHO-GBCI through a partnership with City Cancer Challenge (C/Can), an NGO working to improve access to cancer care. WHO-GBCI Phase 2 Launch Event (May 18, 2026, Geneva, Switzerland - WHA Side Event) The WHO Global Breast Cancer Initiative (WHO-GBCI) is a WHO-led global initiative aimed at reducing disparities in breast cancer mortality. Through its partnership with C/Can, an implementation partner supporting city-level action, the initiative seeks to strengthen breast cancer care systems in low- and middle-income countries. The long term vision of the initiative is to reduce breast cancer mortality by 2.5% annually, with the goal of saving 2.5 million lives over 20 years. Built on three pillars- (1) early detection, (2) timely diagnosis, and (3) comprehensive breast cancer treatment and management-the initiative is working to strengthen healthcare systems in countries and regions. Through implementation partners such as C/Can, the initiative incorporates practical, city-level approaches to strengthen local breast cancer care systems and support national priorities. During Phase 1 of the WHO-GBCI, which began in 2023, efforts were made in four cities-Tbilisi (Georgia), Kumasi (Ghana), Cali (Colombia), and Phnom Penh (Cambodia)-to develop locally-led Breast Cancer Action Plans (BCAPs), train healthcare professionals, and strengthen collaboration with medical institutions. Specifically, the initiative provided breast cancer care services to over 81,800 women and trained more than 450 healthcare professionals. These efforts have helped clarify and organize challenges tailored to the specific circumstances of each country and region and strengthen collaboration among stakeholders. In WHO-GBCI Phase 2 (2026-2028), which begins in 2026, the initiative plans to expand the target regions and cities based on the outcomes of Phase 1 and move the plan into the implementation phase. Efforts will be expanded from the city level to the national level, and initiatives tailored to the specific circumstances of each country and region will be advanced to build sustainable healthcare s...